Publication of the annual report and invitation to the ordinary shareholders’ meeting
March 25 2021 - 4:01PM
Mechelen, Belgium; 25 March 2021; 21.01
CET; regulated information – Galapagos NV (Euronext & NASDAQ:
GLPG) published its annual report for the
financial year 2020.
The annual report for the financial year 2020, including a
review of figures and performance, is available online at
https://www.glpg.com/financial-reports and can also be downloaded
as PDF. Our annual 2020 Form 20-F filing with the SEC is also
available at www.sec.gov/edgar.
Furthermore, Galapagos has the honor to invite
its shareholders, holders of subscription rights, board members,
and statutory auditor to its annual (ordinary) shareholders’
meeting that will be held on Wednesday 28 April 2021 at 2:00 p.m.
(CET) at the Company’s registered office.
The items on the agenda of the ordinary
shareholders’ meeting include, amongst other items, the
reappointments of Dr. Raj Parekh as a non-executive member of the
supervisory board for four years and Katrine Bosley as an
independent non-executive member of the supervisory board for one
year.
In order to be admitted to the shareholders’
meeting, the holders of securities issued by the Company must
comply with article 7:134 of the Belgian Code of Companies and
Associations and article 24 of the Company’s articles of
association, and fulfill the formalities described in the convening
notice. The convening notice and other documents pertaining to the
shareholders’ meeting can be consulted on our website,
www.glpg.com/shareholders-meetings.
In light of the COVID-19 pandemic, it is
currently envisaged that the measures imposed by the Belgian
government to deal with this pandemic, such as the obligation to
guarantee a distance of 1.5 meters between each person, may still
be in effect as of Wednesday 28 April 2021, date of the Company's
annual shareholders' meeting. These measures are in the interest of
the health of individual securities holders, as well as of the
employees of the Company and others who are responsible for
organizing the shareholders' meeting. It can also not be excluded
that the Belgian government will again impose additional measures.
We are monitoring the situation closely and will, if necessary,
disclose additional relevant information and measures affecting the
ordinary general meeting on the Galapagos website
(https://www.glpg.com/shareholders-meetings). In light of this, the
Company recommends that shareholders who wish to participate in the
annual shareholders' meeting exercise as much as practically
possible the right to vote by letter or by proxy to the general
counsel. Moreover, holders of securities of the Company are
encouraged to exercise their right to ask questions related to the
items on the agenda of the general shareholders' meeting in
writing.
About GalapagosGalapagos NV
discovers and develops small molecule medicines with novel modes of
action, several of which show promising patient results and are
currently in late-stage development in multiple diseases. Our
pipeline comprises Phase 3 through to discovery programs in
inflammation, fibrosis, and other indications. Our ambition is to
become a leading global biopharmaceutical company focused on the
discovery, development and commercialization of innovative
medicines. More information at www.glpg.com.
Contacts Investors: Elizabeth
Goodwin VP Investor Relations +1 781 460 1784
Sofie Van Gijsel Senior Director Investor Relations +32 485 19
14 15 ir@glpg.com
Media: Carmen Vroonen Global Head
Communications & Public Affairs +32 473 824 874
Kyra ObolenskySenior Director Corporate Communications +32 491
92 64 35communications@glpg.com
Forward-looking statementsThis
release may contain forward-looking statements. Such
forward-looking statements are not guarantees of future results.
These forward-looking statements speak only as of the date of
publication of this document. Galapagos expressly disclaims any
obligation to update any forward-looking statements in this
document, unless specifically required by law or regulation.
DisclaimerThe contents of our
website, including the annual report for the financial year 2020,
and any other website that may be accessed from our website, shall
not be deemed incorporated by reference in any filing under the
Securities Act of 1933.
Galapagos (EU:GLPG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Galapagos (EU:GLPG)
Historical Stock Chart
From Jul 2023 to Jul 2024